Hemosense (AMEX:HEM)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Hemosense Charts. Click Here for more Hemosense Charts.](/p.php?pid=staticchart&s=A%5EHEM&p=8&t=15)
HemoSense, Inc. (AMEX:HEM) today announced that it will release
financial results for the fiscal first quarter ended December 31, 2006
after market close on Thursday, February 1, 2007. HemoSense management
will host an investment community conference call beginning at 4:30 p.m.
Eastern Time (1:30 p.m. Pacific Time) to discuss those results and
answer questions.
Individuals interested in participating in the conference call may do so
by dialing 877-815-7177 for domestic callers, or 706-634-1178 for
international callers. Those interested in listening to the conference
call live via the Internet may do so by visiting the Investors section
of the company’s Web site at www.hemosense.com.
A telephone replay will be available for 48 hours following the
conclusion of the call by dialing 800-642-1687 for domestic callers, or
706-645-9291 for international callers, and entering reservation code
7091474. A webcast replay will be available for 30 days by visiting the
Investors section on the HemoSense Web site.
About HemoSense
HemoSense is a point-of-care diagnostic healthcare company that
develops, manufactures and markets easy-to-use, handheld blood
coagulation systems for monitoring patients taking warfarin. The
HemoSense INRatio® system, used by healthcare
professionals and patients themselves, consists of a small monitor and
disposable test strips. It provides accurate and convenient measurement
of blood clotting time, or PT/INR values. Routine measurements of PT/INR
are necessary for the safe and effective management of the patient’s
warfarin dosing. INRatio is sold in the United States and
internationally. For more information, visit www.hemosense.com.